Driving new ways of working through Connected Health Ecosystems - Damian O'Co...Innovation Agency
Damian O'Connor discusses how the European Connected Health Alliance is driving news ways of working through connected health ecosystems. O'Connor's presentation introduces the basic principles of these ecosystems, the international network of ecosystems, and the ECHAlliance working groups one of which is a Medicines Optimisation Group.
Presentation by Andrew Cooper, Associate Director Patient Safety, Innovation Agency, at the Emergency Laparotomy Collaborative event on Monday, 17 June at The Foresight Centre, Liverpool.
Fenin en colaboración con el departamento comercial UK Trade and Investment, de la Embajada británica en Madrid, han organizado un foro empresarial dirigido al sector de tecnología sanitaria, con el objetivo de evaluar los sistemas de compras de los sistemas sanitarios de España y Reino Unido (NHS), y conocer las oportunidades de negocio que el NHS representa para empresas españolas de tecnología sanitaria.
Dr Hakim Yadi, Chief Executive Officer for Northern Health Science Alliance (NHSA) opened the May 24th Ecosystem event with this introduction to Connected Health Cities in the North West.
Driving new ways of working through Connected Health Ecosystems - Damian O'Co...Innovation Agency
Damian O'Connor discusses how the European Connected Health Alliance is driving news ways of working through connected health ecosystems. O'Connor's presentation introduces the basic principles of these ecosystems, the international network of ecosystems, and the ECHAlliance working groups one of which is a Medicines Optimisation Group.
Presentation by Andrew Cooper, Associate Director Patient Safety, Innovation Agency, at the Emergency Laparotomy Collaborative event on Monday, 17 June at The Foresight Centre, Liverpool.
Fenin en colaboración con el departamento comercial UK Trade and Investment, de la Embajada británica en Madrid, han organizado un foro empresarial dirigido al sector de tecnología sanitaria, con el objetivo de evaluar los sistemas de compras de los sistemas sanitarios de España y Reino Unido (NHS), y conocer las oportunidades de negocio que el NHS representa para empresas españolas de tecnología sanitaria.
Dr Hakim Yadi, Chief Executive Officer for Northern Health Science Alliance (NHSA) opened the May 24th Ecosystem event with this introduction to Connected Health Cities in the North West.
Marcel de Pender, Slimmer Leven 2010 “Regional Strategy in The Province Noord...Mindtrek
Overview presentation
• Introduction Brainport Region
• Societal changes, technological developments, regulatory
aspects
• Innovation network for Active & Healthy Ageing: Smart
Living”
• Projects & spin-outs companies
• Cooperation
Slimmer Leven 2020
Innovation network for Active
and Healthy Ageing
Presented by:
Marcel de Pender,
Program Director, Slimmer Leven 2020
International Technology Conference Mindtrek 2017
20th - 21st of September, 2017
Tampere, Finland
Victoria Taylor, British Heart Foundation, "Bridging the gap between discovery and commercialisation: A charity's perspective" - slides from Journeys of Health-Tech Innovation: Products to Market
Andy Bleaden - ECO 17: Transforming care through digital healthInnovation Agency
Presentation by Andy Bleaden, International Projects Manager, ECHAlliance at ECO 17: Transforming care through digital health on Tuesday 4 December at Lancaster University, Lancaster
Nicholas Oughtibridge (Principle Author of the Code of Practice for Confidential Information - HSCIC) spoke at the recent "Commissioning in Healthcare show (CiH 2015)".
Areas covered include:
· The role of the code of practice
· What is covered by the Code of Practice on Confidential Information?
· The seven steps in the life of a data collection
· Sharing confidential information with other people to meet legitimate needs
· Plans for revising the Code of Practice on Confidential Information
European Association for Health Information
and Libraries – EAHIL Public Health Information Special Interest Group
Päivi Pekkarinen & Sue Thomas
Scientific Consultation Group (SCG) Meeting of Pan-European Public Health Associations, Federations, Societies,
and Organizations, 2-3 December 2008, ECDC, Stockholm
This presentation was made by Tom LING, Rand Europe, at the 5th Meeting of the joint OECD DELSA/GOV Network on Fiscal Sustainability of Health Systems held on 4-5 February 2016 at the OECD Conference Centre in Paris.
An accreditation scheme for organisations that produce health and care information
Organisations who have The Information Standard produce clear, evidence-based information that is user-tested
Find out more about how we are working with various organisations, in order that we may share information that will help with child protection.
This presentation was delivered at EHI Live.
An accreditation scheme for organisations that produce health and care information
Organisations who have The Information Standard produce clear, evidence-based information that is user-tested
Master presentation from the Lancashire Health MATTERS launch event on Wednesday 22 January 2020 at the UCLan Engineering and Innovation Centre, Preston .
Dr Liz Mear - Welcome to Ecosystem 11 - Digital Innovation in Medicines Optim...Innovation Agency
Dr Liz Mear, Chief Executive of the Innovation Agency, introduces the medicines optimisation programmes in the North West Coast region. She also talks about the role the Innovation Agency plays in the spread and adoption of innovation in healthcare using tools such as the Innovation Exchange and Putting Innovation into Practice.
EngageWell Introduction - Caroline Kenyon, Director of Communications, Innova...Innovation Agency
Caroline Kenyon from the Innovation Agency discusses why healthcare professionals should care about social media as an introduction to the EngageWell event.
Marcel de Pender, Slimmer Leven 2010 “Regional Strategy in The Province Noord...Mindtrek
Overview presentation
• Introduction Brainport Region
• Societal changes, technological developments, regulatory
aspects
• Innovation network for Active & Healthy Ageing: Smart
Living”
• Projects & spin-outs companies
• Cooperation
Slimmer Leven 2020
Innovation network for Active
and Healthy Ageing
Presented by:
Marcel de Pender,
Program Director, Slimmer Leven 2020
International Technology Conference Mindtrek 2017
20th - 21st of September, 2017
Tampere, Finland
Victoria Taylor, British Heart Foundation, "Bridging the gap between discovery and commercialisation: A charity's perspective" - slides from Journeys of Health-Tech Innovation: Products to Market
Andy Bleaden - ECO 17: Transforming care through digital healthInnovation Agency
Presentation by Andy Bleaden, International Projects Manager, ECHAlliance at ECO 17: Transforming care through digital health on Tuesday 4 December at Lancaster University, Lancaster
Nicholas Oughtibridge (Principle Author of the Code of Practice for Confidential Information - HSCIC) spoke at the recent "Commissioning in Healthcare show (CiH 2015)".
Areas covered include:
· The role of the code of practice
· What is covered by the Code of Practice on Confidential Information?
· The seven steps in the life of a data collection
· Sharing confidential information with other people to meet legitimate needs
· Plans for revising the Code of Practice on Confidential Information
European Association for Health Information
and Libraries – EAHIL Public Health Information Special Interest Group
Päivi Pekkarinen & Sue Thomas
Scientific Consultation Group (SCG) Meeting of Pan-European Public Health Associations, Federations, Societies,
and Organizations, 2-3 December 2008, ECDC, Stockholm
This presentation was made by Tom LING, Rand Europe, at the 5th Meeting of the joint OECD DELSA/GOV Network on Fiscal Sustainability of Health Systems held on 4-5 February 2016 at the OECD Conference Centre in Paris.
An accreditation scheme for organisations that produce health and care information
Organisations who have The Information Standard produce clear, evidence-based information that is user-tested
Find out more about how we are working with various organisations, in order that we may share information that will help with child protection.
This presentation was delivered at EHI Live.
An accreditation scheme for organisations that produce health and care information
Organisations who have The Information Standard produce clear, evidence-based information that is user-tested
Master presentation from the Lancashire Health MATTERS launch event on Wednesday 22 January 2020 at the UCLan Engineering and Innovation Centre, Preston .
Dr Liz Mear - Welcome to Ecosystem 11 - Digital Innovation in Medicines Optim...Innovation Agency
Dr Liz Mear, Chief Executive of the Innovation Agency, introduces the medicines optimisation programmes in the North West Coast region. She also talks about the role the Innovation Agency plays in the spread and adoption of innovation in healthcare using tools such as the Innovation Exchange and Putting Innovation into Practice.
EngageWell Introduction - Caroline Kenyon, Director of Communications, Innova...Innovation Agency
Caroline Kenyon from the Innovation Agency discusses why healthcare professionals should care about social media as an introduction to the EngageWell event.
ECO 11: Centre for Pharmacy Innovation - Professor Alison EwingInnovation Agency
Professor Alison Ewing introduces the Centre for Pharmacy Innovation, a collaboration between Liverpool John Moores University, Royal Liverpool and Broadgreen University Hospitals, and Lloyds Pharmacy.
Dr Stuart Berry explains how and why he uses social media as a GP, his experiences so far, and his suggestions and top tips for making the most of social media in a healthcare setting.
We are making two points in this presentation. First, health itself is the greatest wealth. Second, if one is healthy only than he/she can work productively for income generation activities. In addition, we will mention a few proven practices by which we can maintain our health.
The Personal Finance and Nutrition and Wellness teams of the Military Families Learning Network will be joining together to present this 90-minute webinar that will focus on the crossover effect of positive health behaviors and positive financial behaviors. As Drs. Ensle and O’Neill will discuss, research has found a strong correlation between health and wealth. This webinar will discuss those correlations and ways to motivate clients to adopt positive behaviors in both parts of their lives.
Multiprofessional social media communities: improving health and care - Naomi...Innovation Agency
Naomi McVey highlights how multiprofessional social media communities are supporting improvements in health and care with examples and further thoughts for event attendees.
The Internet Of Everything - How To Make It SmarterAtooma Inc
Companies really know the importance to enter the IoT space today because, if you don't do it.... you'll lose against your competitors.
But, nowadays, they rely on static Apps and products that not really interact with user lives. As a result, users are not engaged and IoT products don't scale.
Giving an example, insurance apps are only showcases of personal data, with simple connections to social networks and nothing more. This can’t be called IoT.
How can companies leverage the IoE and Big Data capabilities in order to better profile users, enhance his Company’s Digital strategy and win the IoT battle against the competitors?
Here's the answer.
Using social media to engage communities and consult - Alex TalbottInnovation Agency
Alex Talbott discusses the role the social media plays in engaging with communities and using these channels to achieve the aim of involving communities in NHS commissioning decisions.
Amanda Ricchiuti of Blackpool Care Home Support Team presneted the work of this team who have been monitoring local care homes using telehealth equipment to prevent admissions to hospital.
Dr Liz Mear, Chief Executive of the Innovation Agency presented at NHS Confed 17 about the NHS’ role in growing local economies and how Academic Health and Science Networks (AHSNs) can generate economic growth in life sciences through their role as catalysts, connectors and collaborators by spreading innovation, advancing health technology and improving healthcare
Putting innovation into practice (NHS vs Widnes Vikings)Richard Harding
Where is the Front Door to the NHS?
How do we procure innovation and innovate procurement in Health?
What does health want?
How does an SME leverage Local Infrastructure
Presentation by Andy Cairns, Programme Manager, Innovation Agency: Welcome and introduction at the Funding - Liverpool City Region SME workshop on Thursday 7 February 2019 at The Accelerator, Liverpool
Let us share with you our successes, impacts and performance over the past year. The Innovation Agency is proud to bring you our Annual Report for 2015/16.
Academic Health Science Networks supporting strategic commissioningInnovation Agency
Dr Liz Mear, Chief Executive of the Innovation Agency, presented at NHS Confed 17 on Academic Health Science Networks (AHSNs) supporting strategic commissioning and bringing innovators, commissioners, clinicians and patients to together to develop closer collaboration and a demonstrably clearer understanding of NHS needs and opportunities.
Karen Livingstone - ECO 17: Transforming care through digital healthInnovation Agency
Presentation by Karen Livingstone, Director of Innovation Exchange and SBRI Healthcare, NHS England: Transforming Health and Social Care Services - The Innovation Exchange and SBRI Healthcare at ECO 17: Transforming care through digital health on Tuesday 4 December at Lancaster University, Lancaster
Similar to Health is Wealth: Supporting and Spreading Innovation - Dr Liz Mear (20)
Presentations by Tawfiq Choudhury and Rocco Hadland from the second webinar of the Mastering Cholesterol webinar series on Thursday 11 May 2023, focusing on Statins.
Targeting lipids: a primary and secondary care perspectiveInnovation Agency
Presentations by Dr Sue Kemsley and Dr Gavin Galasko from the first webinar of the Mastering Cholesterol webinar series on Thursday 26 January 2023, focusing on lipid management from a primary and secondary care perspective.
Supporting the optimal detection and management of BP in Primary CareInnovation Agency
Presentation by Jane Briers, Programme Manager - Innovation Agency at the Supporting recovery in Primary Care using Proactive Frameworks for Long Term Conditions event on Thursday 15 September 2022.
Presentation by Dr Lauren Moorcroft, GP Partner - Brookvale Practice at the Supporting recovery in Primary Care using Proactive Frameworks for Long Term Conditions event on Thursday 15 September 2022.
Introduction to Supporting recovery in Primary Care using Proactive Framework...Innovation Agency
Presentation by Julia Reynolds, Associate Director for Transformation - Innovation Agency at the Supporting recovery in Primary Care using Proactive Frameworks for Long Term Conditions event on Thursday 15 September 2022.
Presentation by Paul Brain, Project Manager at the Excel in Health series - Introduction to data webinar on Monday 6 June 2022.
In this session we discussed how SMEs can use data to grow their business and access new opportunities in the market.
Presentations by Mike Kenny, Acting Co-Director of Enterprise and Growth, Innovation Agency and Dr Neil Paul, a GP and Board Member with Cheshire East ICP at the Excel in Health: Understanding the NHS Landscape webinar on Wednesday 11 May 2022.
LCR and Cheshire and Merseyside Health MATTERS networking eventInnovation Agency
Master slide deck from the LCR and Cheshire and Merseyside Health MATTERS networking event on Wednesday 24 November 2021 at Sci-Tech Daresbury Laboratory.
Master slide deck from the Excel in Health webinar series: The NHS landscape presentation.
This webinar identifies the structure of the NHS and its national priorities.
The session will cover the following topics:
Understand the structure of the NHS
Understand the national priorities of the NHS
Recognise the barriers to sale
Adv. biopharm. APPLICATION OF PHARMACOKINETICS : TARGETED DRUG DELIVERY SYSTEMSAkankshaAshtankar
MIP 201T & MPH 202T
ADVANCED BIOPHARMACEUTICS & PHARMACOKINETICS : UNIT 5
APPLICATION OF PHARMACOKINETICS : TARGETED DRUG DELIVERY SYSTEMS By - AKANKSHA ASHTANKAR
Title: Sense of Smell
Presenter: Dr. Faiza, Assistant Professor of Physiology
Qualifications:
MBBS (Best Graduate, AIMC Lahore)
FCPS Physiology
ICMT, CHPE, DHPE (STMU)
MPH (GC University, Faisalabad)
MBA (Virtual University of Pakistan)
Learning Objectives:
Describe the primary categories of smells and the concept of odor blindness.
Explain the structure and location of the olfactory membrane and mucosa, including the types and roles of cells involved in olfaction.
Describe the pathway and mechanisms of olfactory signal transmission from the olfactory receptors to the brain.
Illustrate the biochemical cascade triggered by odorant binding to olfactory receptors, including the role of G-proteins and second messengers in generating an action potential.
Identify different types of olfactory disorders such as anosmia, hyposmia, hyperosmia, and dysosmia, including their potential causes.
Key Topics:
Olfactory Genes:
3% of the human genome accounts for olfactory genes.
400 genes for odorant receptors.
Olfactory Membrane:
Located in the superior part of the nasal cavity.
Medially: Folds downward along the superior septum.
Laterally: Folds over the superior turbinate and upper surface of the middle turbinate.
Total surface area: 5-10 square centimeters.
Olfactory Mucosa:
Olfactory Cells: Bipolar nerve cells derived from the CNS (100 million), with 4-25 olfactory cilia per cell.
Sustentacular Cells: Produce mucus and maintain ionic and molecular environment.
Basal Cells: Replace worn-out olfactory cells with an average lifespan of 1-2 months.
Bowman’s Gland: Secretes mucus.
Stimulation of Olfactory Cells:
Odorant dissolves in mucus and attaches to receptors on olfactory cilia.
Involves a cascade effect through G-proteins and second messengers, leading to depolarization and action potential generation in the olfactory nerve.
Quality of a Good Odorant:
Small (3-20 Carbon atoms), volatile, water-soluble, and lipid-soluble.
Facilitated by odorant-binding proteins in mucus.
Membrane Potential and Action Potential:
Resting membrane potential: -55mV.
Action potential frequency in the olfactory nerve increases with odorant strength.
Adaptation Towards the Sense of Smell:
Rapid adaptation within the first second, with further slow adaptation.
Psychological adaptation greater than receptor adaptation, involving feedback inhibition from the central nervous system.
Primary Sensations of Smell:
Camphoraceous, Musky, Floral, Pepperminty, Ethereal, Pungent, Putrid.
Odor Detection Threshold:
Examples: Hydrogen sulfide (0.0005 ppm), Methyl-mercaptan (0.002 ppm).
Some toxic substances are odorless at lethal concentrations.
Characteristics of Smell:
Odor blindness for single substances due to lack of appropriate receptor protein.
Behavioral and emotional influences of smell.
Transmission of Olfactory Signals:
From olfactory cells to glomeruli in the olfactory bulb, involving lateral inhibition.
Primitive, less old, and new olfactory systems with different path
Title: Sense of Taste
Presenter: Dr. Faiza, Assistant Professor of Physiology
Qualifications:
MBBS (Best Graduate, AIMC Lahore)
FCPS Physiology
ICMT, CHPE, DHPE (STMU)
MPH (GC University, Faisalabad)
MBA (Virtual University of Pakistan)
Learning Objectives:
Describe the structure and function of taste buds.
Describe the relationship between the taste threshold and taste index of common substances.
Explain the chemical basis and signal transduction of taste perception for each type of primary taste sensation.
Recognize different abnormalities of taste perception and their causes.
Key Topics:
Significance of Taste Sensation:
Differentiation between pleasant and harmful food
Influence on behavior
Selection of food based on metabolic needs
Receptors of Taste:
Taste buds on the tongue
Influence of sense of smell, texture of food, and pain stimulation (e.g., by pepper)
Primary and Secondary Taste Sensations:
Primary taste sensations: Sweet, Sour, Salty, Bitter, Umami
Chemical basis and signal transduction mechanisms for each taste
Taste Threshold and Index:
Taste threshold values for Sweet (sucrose), Salty (NaCl), Sour (HCl), and Bitter (Quinine)
Taste index relationship: Inversely proportional to taste threshold
Taste Blindness:
Inability to taste certain substances, particularly thiourea compounds
Example: Phenylthiocarbamide
Structure and Function of Taste Buds:
Composition: Epithelial cells, Sustentacular/Supporting cells, Taste cells, Basal cells
Features: Taste pores, Taste hairs/microvilli, and Taste nerve fibers
Location of Taste Buds:
Found in papillae of the tongue (Fungiform, Circumvallate, Foliate)
Also present on the palate, tonsillar pillars, epiglottis, and proximal esophagus
Mechanism of Taste Stimulation:
Interaction of taste substances with receptors on microvilli
Signal transduction pathways for Umami, Sweet, Bitter, Sour, and Salty tastes
Taste Sensitivity and Adaptation:
Decrease in sensitivity with age
Rapid adaptation of taste sensation
Role of Saliva in Taste:
Dissolution of tastants to reach receptors
Washing away the stimulus
Taste Preferences and Aversions:
Mechanisms behind taste preference and aversion
Influence of receptors and neural pathways
Impact of Sensory Nerve Damage:
Degeneration of taste buds if the sensory nerve fiber is cut
Abnormalities of Taste Detection:
Conditions: Ageusia, Hypogeusia, Dysgeusia (parageusia)
Causes: Nerve damage, neurological disorders, infections, poor oral hygiene, adverse drug effects, deficiencies, aging, tobacco use, altered neurotransmitter levels
Neurotransmitters and Taste Threshold:
Effects of serotonin (5-HT) and norepinephrine (NE) on taste sensitivity
Supertasters:
25% of the population with heightened sensitivity to taste, especially bitterness
Increased number of fungiform papillae
These simplified slides by Dr. Sidra Arshad present an overview of the non-respiratory functions of the respiratory tract.
Learning objectives:
1. Enlist the non-respiratory functions of the respiratory tract
2. Briefly explain how these functions are carried out
3. Discuss the significance of dead space
4. Differentiate between minute ventilation and alveolar ventilation
5. Describe the cough and sneeze reflexes
Study Resources:
1. Chapter 39, Guyton and Hall Textbook of Medical Physiology, 14th edition
2. Chapter 34, Ganong’s Review of Medical Physiology, 26th edition
3. Chapter 17, Human Physiology by Lauralee Sherwood, 9th edition
4. Non-respiratory functions of the lungs https://academic.oup.com/bjaed/article/13/3/98/278874
Recomendações da OMS sobre cuidados maternos e neonatais para uma experiência pós-natal positiva.
Em consonância com os ODS – Objetivos do Desenvolvimento Sustentável e a Estratégia Global para a Saúde das Mulheres, Crianças e Adolescentes, e aplicando uma abordagem baseada nos direitos humanos, os esforços de cuidados pós-natais devem expandir-se para além da cobertura e da simples sobrevivência, de modo a incluir cuidados de qualidade.
Estas diretrizes visam melhorar a qualidade dos cuidados pós-natais essenciais e de rotina prestados às mulheres e aos recém-nascidos, com o objetivo final de melhorar a saúde e o bem-estar materno e neonatal.
Uma “experiência pós-natal positiva” é um resultado importante para todas as mulheres que dão à luz e para os seus recém-nascidos, estabelecendo as bases para a melhoria da saúde e do bem-estar a curto e longo prazo. Uma experiência pós-natal positiva é definida como aquela em que as mulheres, pessoas que gestam, os recém-nascidos, os casais, os pais, os cuidadores e as famílias recebem informação consistente, garantia e apoio de profissionais de saúde motivados; e onde um sistema de saúde flexível e com recursos reconheça as necessidades das mulheres e dos bebês e respeite o seu contexto cultural.
Estas diretrizes consolidadas apresentam algumas recomendações novas e já bem fundamentadas sobre cuidados pós-natais de rotina para mulheres e neonatos que recebem cuidados no pós-parto em unidades de saúde ou na comunidade, independentemente dos recursos disponíveis.
É fornecido um conjunto abrangente de recomendações para cuidados durante o período puerperal, com ênfase nos cuidados essenciais que todas as mulheres e recém-nascidos devem receber, e com a devida atenção à qualidade dos cuidados; isto é, a entrega e a experiência do cuidado recebido. Estas diretrizes atualizam e ampliam as recomendações da OMS de 2014 sobre cuidados pós-natais da mãe e do recém-nascido e complementam as atuais diretrizes da OMS sobre a gestão de complicações pós-natais.
O estabelecimento da amamentação e o manejo das principais intercorrências é contemplada.
Recomendamos muito.
Vamos discutir essas recomendações no nosso curso de pós-graduação em Aleitamento no Instituto Ciclos.
Esta publicação só está disponível em inglês até o momento.
Prof. Marcus Renato de Carvalho
www.agostodourado.com
Knee anatomy and clinical tests 2024.pdfvimalpl1234
This includes all relevant anatomy and clinical tests compiled from standard textbooks, Campbell,netter etc..It is comprehensive and best suited for orthopaedicians and orthopaedic residents.
ARTIFICIAL INTELLIGENCE IN HEALTHCARE.pdfAnujkumaranit
Artificial intelligence (AI) refers to the simulation of human intelligence processes by machines, especially computer systems. It encompasses tasks such as learning, reasoning, problem-solving, perception, and language understanding. AI technologies are revolutionizing various fields, from healthcare to finance, by enabling machines to perform tasks that typically require human intelligence.
Ozempic: Preoperative Management of Patients on GLP-1 Receptor Agonists Saeid Safari
Preoperative Management of Patients on GLP-1 Receptor Agonists like Ozempic and Semiglutide
ASA GUIDELINE
NYSORA Guideline
2 Case Reports of Gastric Ultrasound
TEST BANK for Operations Management, 14th Edition by William J. Stevenson, Ve...kevinkariuki227
TEST BANK for Operations Management, 14th Edition by William J. Stevenson, Verified Chapters 1 - 19, Complete Newest Version.pdf
TEST BANK for Operations Management, 14th Edition by William J. Stevenson, Verified Chapters 1 - 19, Complete Newest Version.pdf
3. Why AHSNs are unique
Delivering benefits to our local
members
- Aligning to members’ priorities
- Support local delivery of New Care
Models for health and social care
- Collaboration with local transformation
&
improvement partners
Spreading innovation at pace &
scale / supporting companies to
grow
- Promoting economic growth
- Diffusing innovation
- Improving Patient Safety
Supporting the NHS to deliver a
step change, e.g.
- NHS Innovation Accelerator
- Test Beds
- Personalised medicine / Genomics
Medicine Centres
Pan-AHSN collaboration
- Mobilising our shared expertise &
resources to support national spread
of innovation
Transforming
Health, Generating
Economic Growth,
advancing
technology
7. All applicants undergo a rigorous
assessment process to join the
NIA
• Application form
• Review by a range of assessors
• Interview
• NICE involvement
• Final decision by NHS England’s
Medical Director:
Professor Sir Bruce Keogh
8. Fellows represent a range of
innovations
Earlier diagnosis
Brush DJ
AliveCor
Scarred Liver Project
Supporting people to
live healthier lives
MyCOPD
i-thrive
Sleepio
Owise
NeuroResponse
HealthCoaching
Safest, highest quality health care
Non injectable arterial connector (NIC)
Episcissors-60
PneuX Prevention System
NerveCentre
Digital health
Sapoientia
Joint Dementia Research
HealthUnlocked
Patients Know Best
9. Impressive results achieved to
date:
• 345+ additional NHS providers and
commissioners using NIA innovations
• £17m+ raised in funding for life science
businesses
• Led to Innovation and Technology Tariff
10. • Creating solutions that will improve patient care,
improve efficiency for the NHS and enhance
economic growth for British companies.
• NHS England backed programme that provides
funding to companies to solve healthcare
problems.
• 15 Academic Health Science Networks (AHSNs)
and NHS England leads to give detailed
specifications to industry for some of our most
pressing health needs.
• 15/16 awarded contracts with a total value of
£17.5m to 44 companies.
SBRI Healthcare
13. The Innovation Agency ERDF Programmes
Business Connect
Lancashire ERDF
Programme:
Lead Partner with
Lancaster University as
delivery partner
Business Connect
Liverpool / Health
Enterprise Hub ERDF
Programme: Delivery
Partner with Liverpool
CCG Lead Partner
Business Connect
Cheshire & Warrington
ERDF Programme: Lead
Partner with GM AHSN as
Delivery Partner (nb both
AHSNs cover different parts of
Cheshire)
14. Investment to support change
culture - Innovation Scouts
Champions of change, Creating a culture of innovation;
part of the AHSNs regional networks for supporting and
implementing new technologies and systems
15. The HEH Innovation Exchange is part funded by the
European Regional Development Fund
16. Health Enterprise Hub (HEH)
Innovation Exchange Project
• Project to grow Liverpool City Region (LCR) SMEs
• Supports the development and commercialisation
of innovative SME products and services for the
health and care sector
• Enhances LCR’s reputation as a centre of excellence
in developing and scaling innovative solutions
• Enables the healthcare sector to deliver more
effectively and efficiently
17.
18. SME support
• Procurement
• Funding
• Clinical evaluation
• Health Economics
• Sales Pitch Development
• Signposting
• Product Development
• Commercialisation
19. Products and services that
focus on:
•Prevention
•Increasing self management
•Allowing remote management
•Increasing community provision
•Improving and speeding up diagnostics
20.
21. Outcomes . . .
The £6.5m over the next 3 years will help:
• Support 282 healthcare SMEs
• 156 SMEs recruit additional staff due to expansion
• 34 SMEs launch new products into the NHS
• 74 SMEs develop new products for the NHS
• 49 New SMEs will be created
22. Some of our regional SMEs in the
Innovation Zone
• Damibu
• DCD
• Ice Creates
• Needle Smart
• Onteca
• Orcha
• Red Ninja
• Rescon
• Smyl Connect
• Studio Mashbo
• Wellbeing
Enterprises
Business Support
• HEH Innovation
Exchange
• Invest Liverpool
23. If you would like to work with us and make a difference
to the lives of millions of local people, please contact:
Dr Liz Mear
Chief Executive
E: Liz.Mear@innovationagencynwc.nhs.uk
T: 01772 520260
M: 07891 698692
Lisa Butland
Director of Innovation and Research
E: Lisa.Butland@innovationagencynwc.nhs.uk
T: 01772 520263
M: 07900 715261
Dr Phil Jennings
Interim Medical Director
E: philip.jennings@innovationagencynwc.nhs.uk
T: 01772 520258
M: 07538 902165
Lorna Green
Commercial Director
E: Lorna.Green@innovationagencynwc.nhs.uk
T: 01772 520259
M: 07507 845982
Email: info@innovationagencynwc.nhs.uk Twitter: @innovationnwc
www.innovationagencynwc.nhs.uk
Caroline Kenyon
Director of Communications and Engagement
E: caroline.kenyon@innovationagencynwc.nhs.uk
T: 01772 520256
M: 07950 866394
23